Genetic susceptibility and oxidative stress in prostate cancer: integrated model with implications for prevention.
Klein
Eric A
EA
Section of Urologic Oncology, Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, Ohio 44122, USA. kleine@ccf.org
Casey
Graham
G
Silverman
Robert
R
D000726:Androgen Antagonists / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000975:Antioxidants / Q000627:therapeutic use; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D018384:Oxidative Stress / Q000235:genetics*; D011379:Prognosis; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism / Q000517:prevention & control*
D000726:Androgen Antagonists; D000893:Anti-Inflammatory Agents; D000975:Antioxidants